Systrade AG
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed July 12, 2024), Systrade AG reported 5 stock positions worth $58.4 million. Its top holding was Alpha Metallurgical Resource (AMR) at 92.1% of the portfolio, followed by UBS Group AG-Reg (UBS, 5.0%) and Biontech SE-ADR (BNTX, 1.4%). Compared with Q1 2024, it opened 1 new position and reduced 2. The biggest buy was a new position in UBS Group AG-Reg (UBS) and the biggest sale Alpha Metallurgical Resource (AMR, shares −20%).
- Most Recent 13F
- Q2 2026
- Location
- VADUZ, N2
- CIK
- 0001818160
- Portfolio Value
- $58.4M (Q2 2024)
- SEC Filing
- 0001085146-24-002909 ↗ filed Jul 12, 2024
Holdings Value
Holdings 5 stocks · $58.4M
| AMR Alpha Metallurgical Resource | 92.12% | 191,900 | $53.8M | Reduce -20.0% |
| UBS UBS Group AG-Reg | 5.02% | 100,000 | $2.9M | New |
| BNTX Biontech SE-ADR | 1.38% | 10,000 | $804K | No change |
| YPF YPF S.A.-Sponsored ADR filed as YPF SOCIEDAD ANONIMA | 0.86% | 25,000 | $503K | No change |
| SHEL Shell PLC-ADR | 0.62% | 5,000 | $361K | Reduce -80.0% |
Portfolio Sells Q1 2024 → Q2 2024
Portfolio Buys Q1 2024 → Q2 2024
| UBS UBS Group AG-Reg | New | 5.02% | +5.02 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 14 | $159.7M | AMR, IBKR, UBS, NTRA, CRESY |
| Q1 2026 | 11 | $149.0M | AMR, IBKR, UBS, CRESY, NTRA |
| Q4 2025 | 15 | $163.9M | AMR, IBKR, UBS, CRESY, NTRA |
| Q3 2025 | 12 | $135.4M | B, IBKR, UBS, CRESY, LOMA |
| Q2 2025 | 13 | $88.3M | B, UBS, AMZN, NEM, CRESY |
| Q1 2025 | 13 | $71.8M | B, UBS, NEM, CRESY, YPF |
| Q4 2024 | 13 | $58.6M | B, UBS, NEM, YPF, CRESY |
| Q3 2024 | 7 | $47.6M | B, UBS, VAL, BABA, BNTX |
| Q2 2024 | 5 | $58.4M | AMR, UBS, BNTX, YPF, SHEL |
| Q1 2024 | 4 | $82.6M | AMR, SHEL, BNTX, YPF |